Clinical liver tissue specimens from patients with fibrosis were collected, and the expression levels of ATG16L1 in liver tissues were assessed using methods such as quantitative reverse transcription PCR, western blot, H&E staining, immunohistochemistry, and immunofluorescence. The gene discussed is ATG16L1; the disease is fibrosis.